Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (21-30 of 248) with videos related to

Pageof 25
Sort By:
Physical and Engineering Sciences in Medicine|December 2, 2021
In the future simulations will replace clinical trialsMartin A Ebert, Val Gebski, Clive Baldock
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
A randomized trial evaluating rigid immobilization for pelvic irradiationAndrew Kneebone, Val Gebski, Nicole Hogendoorn, et al.
The New England Journal of Medicine|September 17, 2004
Noninvasive ventilationWilliam O Tarnow-Mordi, Val Gebski, Anne Cust
Journal of Speech, Language, and Hearing Research : JSLHR|May 11, 2002
Statistical power in stuttering research: a tutorialMark Jones, Val Gebski, Mark Onslow, et al.
Pharmaceutical Statistics|October 2, 2020
Recurrent time-to-event models with ordinal outcomesVal Gebski, Karen Byth, Rebecca Asher, et al.
Pharmaceutical Statistics|March 18, 2021
Using recurrent time-to-event models with multinomial outcomes to generate toxicity profilesVal Gebski, Ian Marschner, Rebecca Asher, et al.
International Journal of Epidemiology|February 15, 2018
Data maturity and follow-up in time-to-event analysesVal Gebski, Valérie Garès, Emma Gibbs, et al.
Head & Neck|January 1, 2005
Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neckMichael J Veness, Gary J Morgan, Val Gebski
International Journal of Radiation Oncology, Biology, Physics|November 27, 2009
The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patientsMichael Veness, Matthew Foote, Val Gebski, et al.
The Medical Journal of Australia|November 14, 2002
Randomisation in clinical trialsElaine M Beller, Val Gebski, Anthony C Keech
Pageof 25

Showing results (21-30 of 248) with videos related to

Sort By:
Pageof 25
Physical and Engineering Sciences in Medicine|December 2, 2021
In the future simulations will replace clinical trialsMartin A Ebert, Val Gebski, Clive Baldock
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
A randomized trial evaluating rigid immobilization for pelvic irradiationAndrew Kneebone, Val Gebski, Nicole Hogendoorn, et al.
The New England Journal of Medicine|September 17, 2004
Noninvasive ventilationWilliam O Tarnow-Mordi, Val Gebski, Anne Cust
Journal of Speech, Language, and Hearing Research : JSLHR|May 11, 2002
Statistical power in stuttering research: a tutorialMark Jones, Val Gebski, Mark Onslow, et al.
Pharmaceutical Statistics|October 2, 2020
Recurrent time-to-event models with ordinal outcomesVal Gebski, Karen Byth, Rebecca Asher, et al.
Pharmaceutical Statistics|March 18, 2021
Using recurrent time-to-event models with multinomial outcomes to generate toxicity profilesVal Gebski, Ian Marschner, Rebecca Asher, et al.
International Journal of Epidemiology|February 15, 2018
Data maturity and follow-up in time-to-event analysesVal Gebski, Valérie Garès, Emma Gibbs, et al.
Head & Neck|January 1, 2005
Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neckMichael J Veness, Gary J Morgan, Val Gebski
International Journal of Radiation Oncology, Biology, Physics|November 27, 2009
The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patientsMichael Veness, Matthew Foote, Val Gebski, et al.
The Medical Journal of Australia|November 14, 2002
Randomisation in clinical trialsElaine M Beller, Val Gebski, Anthony C Keech
Pageof 25